Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-23-064584
Filing Date
2023-11-16
Accepted
2023-11-16 17:45:43
Documents
1
Period of Report
2023-11-02

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4254
  Complete submission text file 0000950170-23-064584.txt   5607
Mailing Address 1000 MARINA BLVD STE 200 BRISBANE CA 94005
Business Address
BERGER FRANKLIN M (Reporting) CIK: 0001273885 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37410 | Film No.: 231415735

Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Issuer) CIK: 0001633932 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations